Walgreens Boots Alliance has declared it will close a “significant portion” of its underperforming stores, which it says make up about 25% of the chain’s store base. Chief executive officer Tim Wentworth made the announcement during the company’s third quarter conference call last month.
by David Pinto, founder of Racher Press: The race for industry supremacy has pivoted in reverse. Is downsizing the best way to grow?
This year healthcare marketing agency Greater Than One decided to shake up its internship program.
Tracy Lopez, who is the head of North America customer service and 3 PL operations at Dr. Reddy’s Laboratories,spoke with Chain Drug Review about her role and how the company maximizes customer satisfaction. CDR: Can you explain what 3 PL operations is? LOPEZ: It’s third-party logistics.
Walgreens Boots Alliance Inc.’s third quarter earnings missed projections and the company cut its full-year profit outlook. Citing a “difficult” environment for shoppers and pharmacies, WBA announced plans to shutter a ‘significant’ number of underperforming stores.
A Texas court has ruled in favor of the National Association of Chain Drug Stores in its lawsuit against the state’s Health and Human Services Commission, which has far-reaching and precedent-setting implications for pharmacies. The Seventh Court of Appeals reversed a trial court’s ruling.
The National Community Pharmacists Association Thursday launched an all-out push for payment reform that educates patients on how pharmacy benefit managers are increasing prescription drug prices.
For as long as most of us can remember, the tug of war between chain drug retailers and their suppliers was one of relatively equal strength. Retailers came to the battle armed with that most valuable of commodities, shelf space.
Aurigene Pharmaceutical Services Ltd., a Dr. Reddy’s Laboratories Ltd. company, inaugurated its biologics facility spread across 70,000 square feet in Genome Valley, a bio cluster in Hyderabad.
Over 100 products are in active clinical development for obesity, and 66 biotech and pharma companies are involved in obesity clinical trials, according to a new GlobalData report.
Alvotech and Dr. Reddy’s Laboratories SA have entered into a license and supply agreement for the commercialization of AVT03, Alvotech’s biosimilar candidate to Prolia and Xgeva (denosumab). The collaboration combines Dr.
CVS Pharmacy has debuted Well Market, a store brand consumables line featuring nutritious snacks, beverages and groceries. “Our goal at CVS Health is to be the most consumer-centric health care solutions company,” said chief merchandising officer Musab Balbale.
The sudden, unexpected demise of Walmart Health marks the end of one phase of the retailer’s drive to enhance access to care, improve patient outcomes and lower costs, and the beginning of a more pharmacy-centric approach to achieving many of the same objectives.
“You are what you eat.” We know that diet is a vital contributor to health. And now, new funding pathways from both the public and private sector are fueling even more momentum for Food is Medicine programs.
CVS Health reported first quarter revenue and earnings that missed Wall Street’s estimates, as increased medical costs hurt its Medicare Advantage business. Adjusted earnings per share for the period were $1.33, well behind analysts’ consensus forecast of $1.69. Revenue of $88.
